Neuronetics (NASDAQ:STIM – Get Free Report) had its target price hoisted by Canaccord Genuity Group from $5.00 to $8.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s target price suggests a potential upside of 61.29% from the stock’s current price. Neuronetics Stock Down ...
Publicado el: 2025-03-07 07:18:46
Autor: MarketBeat News, Fuente: etfdailynews